The Federal Trade Commission has reached a landmark settlement with Express Scripts, addressing allegations of inflated drug prices and rebate-driven formulary exclusions. The agreement bans the PBM ...

The Federal Trade Commission said it has reached a settlement with Express Scripts, resolving an earlier lawsuit that alleged the pharmacy benefit manager artificially inflated insulin drug prices.

Express Scripts announced Monday a new program called InsideRx, aimed at reducing out-of-pocket prescription costs for the uninsured or those with high-deductibles. High price of prescriptions keeps ...

May 1 (Reuters) - Regeneron Pharmaceuticals and Sanofi will cut the net price of their expensive cholesterol drug for Express Scripts customers in exchange for greater patient access, with some ...

The Federal Trade Commission reached a settlement with Cigna’s Express Scripts in a case over alleged inflation of insulin prices, according to a Feb. 4 agency news release. With the move, the FTC ...

Pharmacy Benefit Manager (“PBM”) arrangements have long relied on rebates with limited transparency into true drug costs. Recent regulatory and ...

Nation’s largest Pharmacy Benefits Manager accused of gaming its drug formulary and withholding billions in rebates from PBM customers. NEW YORK--(BUSINESS WIRE)--Today, Bernstein Litowitz Berger & ...